TOPLINE:
For patients with gastric cancer, extending regular follow-up beyond the typical 5 years after gastrectomy was associated with improved overall and post-recurrence survival rates, new data from a retrospective analysis showed.
METHODOLOGY:
- Currently, postgastrectomy cancer surveillance typically lasts 5 years, although some centers now monitor patients beyond this point.
- To investigate the potential benefit of extended surveillance, researchers used Korean National Health Insurance claims data to identify 40,468 patients with gastric cancer who were disease-free 5 years after gastrectomy — 14,294 received extended regular follow-up visits and 26,174 did not.
- The extended regular follow-up group was defined as having endoscopy or abdominopelvic CT between 2 months and 2 years before diagnosis of late recurrence or gastric remnant cancer and having two or more examinations between 5.5 and 8.5 years after gastrectomy. Late recurrence was a recurrence diagnosed 5 years after gastrectomy.
- Researchers used Cox proportional hazards regression to evaluate the independent association between follow-up and overall and post-recurrence survival rates.
TAKEAWAY:
- Overall, 5 years postgastrectomy, the incidence of late recurrence or gastric remnant cancer was 7.8% — 4.0% between 5 and 10 years (1610 of 40,468 patients) and 9.4% after 10 years (1528 of 16,287 patients).
- Regular follow-up beyond 5 years was associated with a significant reduction in overall mortality — from 49.4% to 36.9% at 15 years (P .001). Overall survival after late recurrence or gastric remnant cancer also improved significantly with extended regular follow-up, with the 5-year post-recurrence survival rate increasing from 32.7% to 71.1% (P .001).
- The combination of endoscopy and abdominopelvic CT provided the highest 5-year post-recurrence survival rate (74.5%) compared with endoscopy alone (54.5%) or CT alone (47.1%).
- A time interval of more than 2 years between a previous endoscopy or abdominopelvic CT and diagnosis of late recurrence or gastric remnant cancer significantly decreased post-recurrence survival (hazard ratio [HR], 1.72 for endoscopy and HR, 1.48 for abdominopelvic CT).
IN PRACTICE:
“These findings suggest that extended regular follow-up after 5 years postgastrectomy should be implemented clinically and that current practice and value of follow-up protocols in postoperative care of patients with gastric cancer be reconsidered,” the authors concluded.
The authors of an accompanying commentary cautioned that while the study “successfully establishes groundwork for extending surveillance of gastric cancer in high-risk populations, more work is needed to strategically identify those who would benefit most from extended surveillance.”
SOURCE:
The study, with first author Ju-Hee Lee, MD, PhD, Department of Surgery, Hanyang University College of Medicine, Seoul , South Korea, and accompanying commentary were published online on June 18 in JAMA Surgery.
LIMITATIONS:
Recurrent cancer and gastric remnant cancer could not be distinguished from each other because clinical records were not analyzed. The claims database lacked detailed clinical information on individual patients, including cancer stages, and a separate analysis of tumor markers could not be performed.
DISCLOSURES:
The study was funded by a grant from the Korean Gastric Cancer Association. The study authors and commentary authors reported no conflicts of interest.
Source link : https://www.medscape.com/viewarticle/does-extended-post-op-follow-improve-survival-gastric-cancer-2024a1000ctz?src=rss
Author :
Publish date : 2024-07-12 09:35:17
Copyright for syndicated content belongs to the linked Source.